The effect of AT1 receptor blockade on bax and bcl-2 expression in bleomycin-induced pulmonary fibrosis

Daru

Volumn 17, Issue 1, 2009, Pages 53-59

  Safaeian, L ^a   Jafarian, A ^b   Rabbani, M ^a   Mirmohammad, Sadeghi H ^a   Torabinia, N ^c   Alavi, S A ^d  

^a Department of Pharmacology and Toxicology ^*  (Iran)

^b Isfahan Pharmaceutical Sciences Research Center   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Isfahan Science and Technology Town   (Iran)

Author keywords

Bax; Bcl 2; Bleomycin; Losartan; Pulmonary fibrosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BIOTIN; BLEOMYCIN; COLLAGEN; LOSARTAN; PROTEIN BAX; PROTEIN BCL 2; STREPTAVIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG INHIBITION; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LYMPHOCYTE; MACROPHAGE ACTIVATION; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; THERAPY EFFECT; TISSUE FIXATION; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION;

EID: 62649119262     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE, Jr Leinwand LA, Liotta L, Martin GR, Schwartz DA, Schultz GS, Wagner CR, Musson RA. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2002; 166: 236-246.
2. Uhal BD. Apoptosis in lung fibrosis and repair. Chest 2002; 122: 293S-298S.
3. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134: 136-151.
4. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, McAnulty RJ, Laurent GJ. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 286: L156-L164.
5. Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor. Thorax 2004; 59: 31-38.
6. Wang R, Zagariya A, Ibarra-Sunga O, Gidea C, Ang E, Deshmukh S, Chaudhary G, Baraboutis J, Filippatos G, Uhal BD. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol 1999; 276: L885-L889.
7. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, Singhal PC. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002; 283: F173-F180.
8. Ono H, Ishimitsu T. Effects of angiotensin II type 1 and type 2 receptor on apoptosis. Nippon Rinsho 2002; 60: 1887-1892.
9. Wang R, Zagariya A, Ang E, Ibarra-Sunga O, Uhal BD. Fas-induced apoptosis of alveolar epithelial cells requires angiotensin II generation and receptor interaction. Am J Physiol 1999; 277: L1245-1250.
10. Wang R, Alam G, Zagariya A, Gidea C, Pinillos H, Laluda O, Choudhary G, Uhal BD. Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin synthesis de novo. Am J Physiol 2000; 185: 253-259.
11. Li X, Zhuang H, Soledad-Conrad V, Zhang J, Uhal BD. Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo. Am J Physiol 2003; 284: L501-L507.
12. Uhal BD, Gidea C, Bargout R, Bifero A, Ibarra-Sunga O, Papp M, Flynn K, Filippatos G. Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism. Am J Physiol 1998; 275: L1013-L1017.
13. Li X, Rayford H, Uhal BD. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice. Am J Pathol 2003; 163: 2523-2530.
14. Kuwano K, Hagimoto N, Tanaka T, Kawasaki M, Kunitake R, Miyazaki H, Kaneko Y, Matsuba T, Maeyama T, Hara N. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol 2000; 190: 221-229.
15. Plataki M, Koutsopoulos AV, Darivianaki K, Delides G, Siafakas NM, Bouros D. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 2005; 127: 266-274.
16. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-1326.
17. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
18. 1 receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 2002; 282: H1635-H1641.
19. Wang XP, Zhang R, Wu K, Wu L, Dong Y. Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R. Pancreas 2004; 29: 264-270.
20. Kanamori H, Takemura G, Li Y, Okada H, Maruyama R, Aoyama T, Miyata S, Esaki M, Ogino A, Nakagawa M, Ushikoshi H, Kawasaki M, Minatoguchi S, Fujiwara H. Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by olmesartan. Am J Physiol Heart Circ Physiol 2007; 292: H2184-H2194.
21. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41: 467-470.
22. Jafarian-Dehkordi A, Rabbani M, Sadeghi MH, Afshar-Moghaddam N, Alavi SA, Mahmoodi F, Safaeian L. Development and time-course of bleomycin-induced pulmonary fibrosis in NMRI mice. Daru 2007; 15: 1-6.
23. Giorno R. A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 1984; 2: 161-166.
24. Guinee D, Jr Brambilla E, Fleming M, Hayashi T, Rahn M, Koss M, Ferrans V, Travis W. The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am J Pathol 1997; 151: 999-1007.
25. Keogh KA, Standing J, Kane GC, Terzic A, Limper AH. Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice. Eur Respir J 2005; 25: 708-714.
26. Kuwano K, Hagimoto N, Yoshimi M, Maeyama T, Nakanishi Y. Apoptosis signaling pathways as therapeutic targets in lung injury. Letters in Drug Design & Discovery, 2004; 1: 263-268.
27. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 2002; 83: 111-119.
28. Uhal BD, Wang R, Laukka J, Zhuang J, Soledad-Conrad V, Filippatos G Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists. Pharmacol Toxicol 2003; 92: 81-87.
29. Suzuki J, Iwai M, Nakagami H, Wu L, Chen R, Sugaya T, Hamada M, Hiwada K, Horiuchi M. Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 2002; 106: 847-853.
30. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-472.